Search Results - "NION‐LARMURIER, I."

Low counts of Faecalibacterium prausnitzii in colitis microbiota by Sokol, H., Seksik, P., Furet, J.P., Firmesse, O., Nion‐Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., Doré, J.

“…Background: The intestinal microbiota is suspected to play a role in colitis and particularly in inflammatory bowel disease (IBD) pathogenesis. The aim was to…”
Get full text

Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease by Cosnes, J., Sokol, H., Bourrier, A., Nion‐Larmurier, I., Wisniewski, A., Landman, C., Marteau, P., Beaugerie, L., Perez, K., Seksik, P.

“…Summary Background The comparative efficacy of adalimumab (ADA) and infliximab (IFX) in Crohn's disease, and the benefit of initial combotherapy with an…”
Get full text

Management of acute sigmoid volvulus: short- and long-term results by Bruzzi, M., Lefèvre, J. H., Desaint, B., Nion-Larmurier, I., Bennis, M., Chafai, N., Tiret, E., Parc, Y.

“…Aim The best form of prophylactic management of a decompressed sigmoid volvulus (SV) is controversial especially in the elderly. We have studied our experience…”
Get full text

Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine by SEKSIK, P., COSNES, J., SOKOL, H., NION‐LARMURIER, I., GENDRE, J.‐P., BEAUGERIE, L.

“…Summary Background  There are few data on the incidence of benign infections (upper respiratory tract infections, herpes lesions and viral warts) during…”
Get full text

Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery by Cosnes, J, Nion-Larmurier, I, Beaugerie, L, Afchain, P, Tiret, E, Gendre, J-P

“…Background/Aim: Immunosuppressants are now used much earlier in the course of Crohn’s disease; however their effect on the natural history of the disease,…”
Get full text

Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease by Rajca, S., Seksik, P., Bourrier, A., Sokol, H., Nion-Larmurier, I., Beaugerie, L., Cosnes, J.

“…The effects of extra-intestinal cancer on the course of inflammatory bowel disease (IBD) are poorly understood. To evaluate the impact of cancer and its…”
Get full text

Complications of celiac disease by Cosnes, J, Nion-Larmurier, I

“…Numerous complications can occur in celiac disease, nutritional (growth failure in children, malnutrition, vitamin deficiencies), hematologic (anaemia), bone…”
Get full text

Neutropenic enterocolitis in acute myeloblastic leukaemia by Mourra, N, Nion-Larmurier, I, Parc, R, Flejou, J-F

Get full text

Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy by Sokol, Harry, Seksik, Philippe, Carrat, Fabrice, Nion-Larmurier, Isabelle, Vienne, Ariane, Beaugerie, Laurent, Cosnes, Jacques

“…Concomitant use of immunosuppressants (IS) with scheduled infliximab (IFX) maintenance therapy for Crohn's disease (CD) or ulcerative colitis (UC) is debated…”
Get more information

DOP26 Metagenomic and metabolomic profiles in IBD: understanding microbial and metabolic shifts from a large deeply phenotyped cohort by Marius, B, Rolhion, N, Creusot, L, Lefevre, A, Alonso, I, Brot, L, Danne, C, Bourrier, A, Parrot, L, Mélanie, D, Benech, N, Nion-Larmurier, I, Mclellan, P, Landman, C, Beaugerie, L, Seksik, P, Emond, P, Kirchgesner, J, Sokol, H

“…Abstract Background Alterations in gut microbiota composition and functions are involved in the pathogenesis of Inflammatory Bowel Disease (IBD) and the role…”
Get full text

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis by Pineton de Chambrun, Guillaume, Amiot, Aurélien, Bouguen, Guillaume, Viennot, Stéphanie, Altwegg, Romain, Louis, Edouard, Collins, Michael, Fumery, Mathurin, Poullenot, Florian, Armengol, Laura, Buisson, Anthony, Abitbol, Vered, Laharie, David, Seksik, Philippe, Nancey, Stéphane, Blanc, Pierre, Bouhnik, Yoram, Pariente, Benjamin, Peyrin-Biroulet, Laurent, Nachury, Maria, Boschetti, Gilles, Flourié, Bernard, Danion, Pauline, Savoye, Guillaume, brazier, Franck, Loreau, Julien, Beaugerie, Laurent, Sokol, Harry, Nion-Larmurier, I., Bourrier, A., Landman, C., Lefèvre, J., Chafai, N., Bouta, Najima, Funakoshi, Natalie

“…It is a challenge to manage patients with ulcerative proctitis (UP) refractory to standard therapy. We investigated the effectiveness of tumor necrosis factor…”
Get full text

Maladie cœliaque by Nion-Larmurier, I., Cosnes, J.

Get full text

P345 Impact of aphthous colitis at diagnosis on Crohn’s disease outcomes by Delattre, C, Nion-Larmurier, I, Bourrier, A, Landman, C, Le Gall, G, Kirchgesner, J, Sokol, H, Beaugerie, L, Cosnes, J, Seksik, P

“…Abstract Background The natural history of intestinal lesions in Crohn’s disease (CD) is not completely characterised. Extent of the lesions at diagnosis…”
Get full text

P199 Hidradenitis suppurativa associated with Crohn’s disease: An increased risk of permanent stoma by Dumont, L -M, Guegan-Bart, S, Landman, C, Nion-Larmurier, I, Bourrier, A, Sokol, H, Marteau, P, Beaugerie, L, Cosnes, J, Seksik, P

“…Abstract Background Hidradenitis Suppurativa (HS) is a chronic cutaneous, inflammatory disease with strong impact on quality of life. Perineal lesions in…”
Get full text

Development of a small bowel capsule endoscopic index of severity in patients with Crohn's disease by Bourreille, A., Attar, A., Maunoury, V., Simon, M., Aubourg, A., Fumery, Mathurin, Reimund, J. -M., Reenaers, C., Nion-Larmurier, I., Bonaz, B., Filippi, J., Dewit, O., Dray, X., Moreau, J., Altwegg, R., Roblin, X., Stefanescu, C., Mary, J. -Y.

Get full text

P116 What is the prognosis of silent Crohn's disease? by Esch, A., Bourrier, A., Seksik, P., Nion-Larmurier, I., Sokol, H., Beaugerie, L., Cosnes, J.

Get full text

P638 Impact of extra-intestinal cancer diagnosis and treament on inflammatory bowel disease outcome by Rajca, S., Bourrier, A., Sokol, H., Beaugerie, L., Nion-Larmurier, I., Seksik, P., Cosnes, J.

Get full text

Une antibiothérapie ciblée pour l’hidradénite suppurée peut-elle améliorer les symptômes de la maladie de Crohn ? by Delage, M., Treton, X., Bouhnik, Y., Nion-Larmurier, I., Seksik, P., Beaugerie, L., Lam, T., Consigny, P.-H., Lortholary, O., Join-Lambert, O., Nassif, A.S.

“…La maladie de Crohn (MC) est associée à l’hidradénite suppurée (HS) dans environ 2 % des cas. Les antibiotiques (AB) sont utilisés dans l’HS et ponctuellement…”
Get full text

Celiac disease by Nion-Larmurier, I, Cosnes, J

Get full text

Formes alopéciantes de psoriasis paradoxal induit par les anti-TNF-alpha chez des patients atteints de maladie inflammatoire chronique intestinale by Kurihara, F., Seksik, P., Moguelet, P., Chasset, F., Nion-Larmurier, I., Beaugerie, L., Aractingi, S., Guégan, S.

“…Les anti-TNF-alpha ont révolutionné la prise en charge et le pronostic des maladies inflammatoires chroniques. Le psoriasis paradoxal est un effet indésirable…”
Get full text